NYSE:TSLX • US83012A1097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SIXTH STREET SPECIALTY LENDI (TSLX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-18 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2026-03-13 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-18 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2026-02-17 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-17 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-11-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-01 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-09-05 | Clear Street | Initiate | Hold |
| 2025-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-02 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-18 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-02-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 438.087M 41.64% | 482.526M 10.14% | 449.055M -6.94% | 429.27M -4.41% | 437.5M 1.92% | 385.87M -11.80% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 228.902M 35.53% | 262.042M 14.48% | 233.504M -10.89% | 195.55M -16.25% | 189.36M -3.17% | N/A | |
| Operating Margin | 52.25% | 54.31% | 52.00% | 45.55% | 43.28% | N/A | |
| EPS YoY % growth | 2.36 16.83% | 2.36 0.00% | 2.18 -7.63% | 2.03 -6.68% | 2.01 -1.05% | 1.81 -10.31% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.51 -11.78% | 0.51 -9.07% | 0.51 -3.35% | 0.51 0.62% | 0.49 -3.32% | 0.48 -4.86% | 0.49 -4.42% | 0.49 -4.59% |
| Revenue Q2Q % growth | 105.59M -9.21% | 107M -6.97% | 108.4M -0.95% | 108.42M 0.16% | 106.24M 0.62% | 106.27M -0.68% | 107.46M -0.87% | 108.3M -0.11% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 49.766M -21.51% | 49.276M -13.72% | 48.603M -14.92% | N/A | N/A | N/A | N/A | N/A |
All data in USD
17 analysts have analysed TSLX and the average price target is 23.21 USD. This implies a price increase of 31.47% is expected in the next year compared to the current price of 17.65.
SIXTH STREET SPECIALTY LENDI (TSLX) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of SIXTH STREET SPECIALTY LENDI (TSLX) is 0.51 USD and the consensus revenue estimate is 105.59M USD.
The number of analysts covering SIXTH STREET SPECIALTY LENDI (TSLX) is 17.